James R. Tobin, Director at TransMedics Group, Inc. (TMDX), sold 40,000 shares at $159.96 ($6.4M) on 2024-08-08, disclosed to the SEC on 2024-08-09.
Open-market sale of $6.4M TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.96 | 12,664 | $2.0M | 31.6% |
| 2 | $158.96 | 12,664 | $2.0M | 31.6% |
| 3 | $159.96 | 7,336 | $1.2M | 18.4% |
| 4 | $159.96 | 7,336 | $1.2M | 18.4% |
| Total | $159.33 avg | 40,000 | $6.4M | 100% |
| Filing → |
| TMDX | SELL | 2024-03-05 | $2.2M | — | Filing → |
| TMDX | SELL | 2023-11-29 | $701K | — | Filing → |
| TMDX | SELL | 2023-02-27 | $751K | — | Filing → |